Kurkela Satu, Brown David W G
is a medical researcher and currently a fellow in public health microbiology (EUPHEM) at the European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden. Competing interests: none declared.
is the director of the Virus Reference Department, Health Protection Agency, London, UK. Competing interests: none declared.
Medicine (Abingdon). 2009 Oct;37(10):535-540. doi: 10.1016/j.mpmed.2009.07.012. Epub 2009 Sep 19.
Clinical microbiology laboratories increasingly rely on molecular diagnostic techniques. The various formats of nucleic acid amplification are the most frequently used molecular tests in the diagnosis of infectious diseases. In many clinical settings, polymerase chain reaction (PCR) is clearly the method of choice due to its exquisite sensitivity and specificity. Today, many conventional PCR methods are being replaced by real-time PCR, which allows more rapid detection and quantification of the PCR product, as well as detection of different strains of the pathogen by melting curve analysis. The ability to measure the quantity of microbe by quantitative PCR has become increasingly important, providing information on the progression and prognosis of disease, and effectiveness of treatment. Other widely used molecular diagnostic techniques are isothermal amplification methods and nucleic acid hybridization techniques. Microarray is a technique which holds promise and has an exceptional sensitivity and the capacity to detect several pathogens simultaneously. However, microarrays are currently too expensive to be adapted for routine diagnostics, and their diagnostic use requires broad-based nucleic acid amplification prior to analysis which is not well established. Several molecular methods can be used for genotyping, which allows the identification of different subtypes of the pathogen; genotyping plays a role in the risk assessment and management of infections. Clinicians need to recognize the enhanced accuracy and speed of the molecular diagnostic techniques for the diagnosis of infections, but also to understand their limitations. Laboratory results should always be interpreted in the context of the clinical presentation of the patient, and appropriate site, quality, and timing of specimen collection are required for reliable test results.
临床微生物实验室越来越依赖分子诊断技术。核酸扩增的各种形式是传染病诊断中最常用的分子检测方法。在许多临床环境中,由于其极高的灵敏度和特异性,聚合酶链反应(PCR)显然是首选方法。如今,许多传统PCR方法正被实时PCR所取代,实时PCR能够更快速地检测和定量PCR产物,还能通过熔解曲线分析检测病原体的不同菌株。通过定量PCR测量微生物数量的能力变得越来越重要,可为疾病的进展、预后及治疗效果提供信息。其他广泛使用的分子诊断技术是等温扩增方法和核酸杂交技术。微阵列技术前景广阔,具有极高的灵敏度且能同时检测多种病原体。然而,微阵列目前成本过高,无法用于常规诊断,并且其诊断应用在分析前需要进行广泛的核酸扩增,而这一点尚未成熟。几种分子方法可用于基因分型,基因分型能够识别病原体的不同亚型;基因分型在感染的风险评估和管理中发挥作用。临床医生需要认识到分子诊断技术在感染诊断方面提高的准确性和速度,但也要了解其局限性。实验室结果应始终结合患者的临床表现来解读,为获得可靠的检测结果,需要在合适的部位、保证样本质量并在恰当的时间采集样本。